Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Bristol-myers squibb company    crawled time : 13:15    save search

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) + Chemotherapy for Patients with HER2-Negative Advanced or Metastatic Gastric, Gastroesophageal Junction
Published: 2021-09-17 (Crawled : 13:15) - biospace.com/
BMY | $47.84 -0.87% -0.02% 12M twitter stocktwits trandingview |
Health Technology
| | O: -1.14% H: 0.0% C: 0.0%

positive therapy chmp her2+ her2- her2 nivolumab
CG Oncology Announces Clinical Trial Collaboration with Bristol Myers Squibb to Evaluate Oncolytic Immunotherapy CG0070 in Combination with OPDIVO® (nivolumab) in Metastatic Urothelial Cancer
Published: 2021-09-09 (Crawled : 13:15) - biospace.com/
BMY | $47.84 -0.87% -0.02% 12M twitter stocktwits trandingview |
Health Technology
| | O: -0.74% H: 0.49% C: -1.33%

immunotherapy therapy collaboration cancer trial nivolumab
Global Mobile Medical Apps Market to Reach $16.5 Billion by 2026
Published: 2021-07-01 (Crawled : 13:15) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: -0.06% H: 1.6% C: -0.45%
NVS | News | $93.08 -0.13% 0.86% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.05% H: 0.5% C: 0.39%
MDT | News | $79.08 -0.22% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.27% H: 1.39% C: 1.34%
GSK | $39.6 -0.88% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: 0.35% H: 1.18% C: 0.53%
BMY | $47.84 -0.87% -0.02% 12M twitter stocktwits trandingview |
Health Technology
| | O: -0.6% H: 0.48% C: 0.21%
BSX | $67.96 -0.24% 1.53% 6.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.05% H: 1.71% C: 1.36%
ABT | News | $105.9 -3.03% 0.07% 12M twitter stocktwits trandingview |
Health Technology
| | O: -0.28% H: 1.45% C: 1.34%
SNY | News | $46.125 0.71% 0.7% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.36% C: 0.08%
AZN | $68.53 0.39% 0.39% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.05% H: 0.95% C: 0.73%

mobile
Intensity Therapeutics Announces Two Abstracts to Be Presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2021-05-20 (Crawled : 13:15) - biospace.com/
BMY | $47.84 -0.87% -0.02% 12M twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 2.92% C: 2.57%


Gainers vs Losers
56% 44%

Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M twitter stocktwits trandingview |
Health Technology

SINT | $0.0365 59.39% 37.26% 470M twitter stocktwits trandingview |
Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M twitter stocktwits trandingview |
Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M twitter stocktwits trandingview |

GCTK | $0.715 36.27% 26.62% 640K twitter stocktwits trandingview |
Manufacturing

TCON | $2.33 36.26% 26.61% 2M twitter stocktwits trandingview |
Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M twitter stocktwits trandingview |

KZIA | $0.38 30.58% 23.42% 300K twitter stocktwits trandingview |
Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M twitter stocktwits trandingview |
Health Technology

ATNF | $1.91 29.05% 22.51% 310K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.